Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
62.76
+20.82 (49.64%)
At close: Mar 9, 2026, 4:00 PM EDT
62.01
-0.75 (-1.20%)
After-hours: Mar 9, 2026, 4:36 PM EDT
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $5.22 billion as of March 9, 2026. Its market cap has increased by 73.90% in one year.
Market Cap
5.22B
Enterprise Value
4.49B
1-Year Change
73.90%
Ranking
Category
Stock Price
$62.76
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $5.22B, an increase of 3,571.61%. That is a compound annual growth rate of 37.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.49B | 0.74% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.54B |
| CRISPR Therapeutics AG | 5.52B |
| Caris Life Sciences | 5.25B |
| Mirum Pharmaceuticals | 5.21B |
| Immunovant | 5.19B |
| Celcuity | 5.17B |
| CG Oncology | 5.08B |
| Apogee Therapeutics | 5.02B |